Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Veteran's claim for a higher rating for HTN was denied. The claim for non-compensable rating for hypothyroidism from June 9, 2022 to December 9, 2022 was granted. However, the claim for compensable rating for hypothyroidism since December 9, 2022 was denied.

The deciding factor: The medical evidence did not show any signs or symptoms of hypothyroidism after the initial diagnosis in June 2022 and without medication, there were no residuals of disease or medical treatment warranting a compensable rating.

Claimed conditions
Hypertension (HTN), Hypothyroidism
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
10%
Decision date
November 27, 2023
Citation
A23033474

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A23033474.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.